Free Trial
OTCMKTS:ISCO

International Stem Cell (ISCO) Stock Price, News & Analysis

International Stem Cell logo
$0.13 -0.01 (-9.03%)
As of 10/10/2025 10:11 AM Eastern

About International Stem Cell Stock (OTCMKTS:ISCO)

Advanced

Key Stats

Today's Range
$0.13
$0.15
50-Day Range
$0.12
$0.18
52-Week Range
$0.06
$0.27
Volume
677 shs
Average Volume
1,672 shs
Market Capitalization
$1.05 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ISCO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for International Stem Cell and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ISCO Stock News Headlines

Shots officially fired…
Elon Musk just declared war on the wireless giants with a $17 billion spectrum deal that gives SpaceX the rights to deliver direct-to-cell service nationwide — a move tech analyst Jeff Brown says could shape the backbone of the coming space economy and create fortunes on a scale not seen since the rise of NVIDIA.tc pixel
See More Headlines

ISCO Stock Analysis - Frequently Asked Questions

International Stem Cell's stock was trading at $0.0813 on January 1st, 2025. Since then, ISCO stock has increased by 61.1% and is now trading at $0.1310.

International Stem Cell Corp. (OTCMKTS:ISCO) posted its quarterly earnings results on Thursday, August, 14th. The biotechnology company reported $0.01 earnings per share for the quarter. The biotechnology company had revenue of $2.45 million for the quarter.

Shares of ISCO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that International Stem Cell investors own include Canopy Growth (CGC), Aurora Cannabis (ACB), Amarantus Bioscience (AMBS), Fulcrum Therapeutics (FULC), Kutcho Copper (KCCFF), B2Gold (BTG) and Cannabis Wheaton Income (CBWTF).

Company Calendar

Last Earnings
8/14/2025
Today
10/10/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:ISCO
CIK
1355790
Employees
30
Year Founded
2001

Profitability

EPS (Trailing Twelve Months)
($0.04)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$210 thousand
Net Margins
-3.29%
Pretax Margin
-2.62%
Return on Equity
N/A
Return on Assets
-5.63%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.78
Quick Ratio
0.46

Sales & Book Value

Annual Sales
$9.09 million
Price / Sales
0.12
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.49) per share
Price / Book
-0.27

Miscellaneous

Outstanding Shares
8,000,000
Free Float
1,324,000
Market Cap
$1.05 million
Optionable
Not Optionable
Beta
-0.02

Social Links

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (OTCMKTS:ISCO) was last updated on 10/11/2025 by MarketBeat.com Staff
From Our Partners